Reply to: "CardioMEMS in HF patients: study confirms benefit in costs and QALYs, but does not measure QALYs"
ESC Heart Fail
.
2024 Aug;11(4):2475.
doi: 10.1002/ehf2.14820.
Epub 2024 Apr 18.
Authors
Pau Codina
1
2
,
Francesc López-Seguí
3
,
Antoni Bayés-Genís
1
2
Affiliations
1
Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias i Pujol, Badalona, Spain.
2
Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
3
Centre for Health and Social Care Research (CESS), University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
PMID:
38638085
PMCID:
PMC11287294
DOI:
10.1002/ehf2.14820
No abstract available
Publication types
Letter
MeSH terms
Cost-Benefit Analysis*
Heart Failure* / economics
Heart Failure* / therapy
Humans
Quality-Adjusted Life Years*